Stay updated with breaking news from Transthera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tinengotinib has been awarded orphan drug designation from the European Medicines Agency for use in select patients with biliary tract cancer.
/PRNewswire/ -- DelveInsight's Cholangiocarcinoma Market Insights report includes a comprehensive understanding of current treatment practices,...
/PRNewswire/ -- DelveInsight's Intrahepatic Cholangiocarcinoma Market Insights report includes a comprehensive understanding of current treatment practices,...
The prevalence of cholangiocarcinoma has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of cholangiocarcinoma and the
/PRNewswire/ -- 'Cholangiocarcinoma Pipeline Insight – 2023' report provides comprehensive global coverage of pipeline cholangiocarcinoma therapies in various...